Lota S. Zoth - Jan 3, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Lota Zoth
Stock symbol
INO
Transactions as of
Jan 3, 2022
Transactions value $
-$4,815
Form type
4
Date filed
1/5/2022, 03:04 PM
Previous filing
May 24, 2021
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +4.09K +18.69% 26K Jan 3, 2022 Direct F1
transaction INO Common Stock Sale -$4.81K -961 -3.7% $5.01* 25K Jan 5, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -4.09K -100% $0.00* 0 Jan 3, 2022 Common Stock 4.09K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on January 3, 2020; 4,090 shares vested on January 3, 2021; 4,090 shares vested on January 3, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.